CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review, BMC Cancer

PDF] Does CYP2D6 Genotyping have a Role in Guiding Tamoxifen Therapy

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy

Influence of CYP2D6 Polymorphisms on Serum Levels of Tamoxifen Metabolites in Spanish Women with Breast Cancer

Frontiers Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites

CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations - Province - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library

Simplistic representation of the main biotransformation of tamoxifen

Pharmaceuticals, Free Full-Text

Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis

Clinical Relevance of CYP2D6 Genetics for Tamoxifen Response in Breast Cancer